Moreover, while neither Spautin-1 or 2-DG treatment induced apoptosis alone, combination treatment led to robust activation of apoptosis, as indicated by activation and cleavage of CASP3 as well as it’s downstream target PARP in stem cell-like tumor subpopulations (Fig. 6d). The gene discussed is CASP3; the disease is neoplasm.